← Back to Screener
BioLife Solutions Inc. (BLFS)
Price$22.19
Favorite Metrics
Price vs S&P 500 (26W)-25.96%
Price vs S&P 500 (4W)7.62%
Market Capitalization$1.04B
All Metrics
P/CF (Annual)51.87x
Book Value / Share (Quarterly)$7.72
P/TBV (Annual)3.17x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-15.91%
Cash Flow / Share (Quarterly)$-0.01
Price vs S&P 500 (YTD)-12.16%
Gross Margin (TTM)64.56%
Net Profit Margin (TTM)-4.78%
EPS (TTM)$-0.10
10-Day Avg Trading Volume0.40M
EPS Excl Extra (TTM)$-0.10
Revenue Growth (5Y)14.87%
EPS (Annual)$-0.10
ROI (Annual)-1.22%
Gross Margin (Annual)64.56%
Net Profit Margin (5Y Avg)-34.13%
Cash / Share (Quarterly)$1.84
Revenue Growth QoQ (YoY)-8.19%
ROA (Last FY)-1.13%
Revenue Growth TTM (YoY)10.33%
EBITD / Share (TTM)$-0.26
ROE (5Y Avg)-13.48%
Operating Margin (TTM)-17.26%
Cash Flow / Share (Annual)$-0.01
P/B Ratio2.81x
P/B Ratio (Quarterly)3.13x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)10.55x
Net Interest Coverage (TTM)-0.82x
ROA (TTM)-1.16%
EPS Growth QoQ (YoY)-13.93%
EV / EBITDA (TTM)948.82x
EPS Incl Extra (Annual)$-0.10
Current Ratio (Annual)5.94x
Quick Ratio (Quarterly)4.22x
3-Month Avg Trading Volume0.39M
52-Week Price Return1.28%
EV / Free Cash Flow (Annual)403.10x
Revenue / Employee (TTM)$1
Tangible BV / Share (Quarterly)$7.63
P/S Ratio (Annual)10.84x
Asset Turnover (Annual)0.24x
52-Week High$29.62
Operating Margin (5Y Avg)-29.03%
EPS Excl Extra (Annual)$-0.10
CapEx CAGR (5Y)21.39%
Tangible BV CAGR (5Y)16.11%
26-Week Price Return-19.07%
Quick Ratio (Annual)4.22x
13-Week Price Return-9.32%
Total Debt / Equity (Annual)0.01x
Current Ratio (Quarterly)5.94x
Enterprise Value$1,015.239
Revenue / Share Growth (5Y)2.72%
Asset Turnover (TTM)0.24x
Book Value / Share Growth (5Y)4.41%
Revenue / Employee (Annual)$1
Inventory Turnover (Annual)1.15x
Pretax Margin (Annual)-12.56%
Cash / Share (Annual)$1.84
3-Month Return Std Dev50.04%
Gross Margin (5Y Avg)43.72%
Net Income / Employee (TTM)$-0
ROE (Last FY)-1.24%
Net Interest Coverage (Annual)-3.91x
EPS Basic Excl Extra (Annual)$-0.10
P/FCF (TTM)243.30x
Receivables Turnover (TTM)11.24x
Total Debt / Equity (Quarterly)0.01x
EPS Incl Extra (TTM)$-0.10
Receivables Turnover (Annual)11.24x
ROI (TTM)-1.26%
P/S Ratio (TTM)10.84x
Pretax Margin (5Y Avg)-29.13%
Revenue / Share (Annual)$2.01
Tangible BV / Share (Annual)$7.63
Forward P/E150.16x
Price vs S&P 500 (52W)-33.35%
Year-to-Date Return-8.23%
5-Day Price Return9.47%
EPS Normalized (Annual)$-0.10
ROA (5Y Avg)-11.06%
Net Profit Margin (Annual)-4.78%
Month-to-Date Return16.30%
Cash Flow / Share (TTM)$-2.09
EBITD / Share (Annual)$-0.30
Operating Margin (Annual)-17.26%
LT Debt / Equity (Annual)0.00x
P/CF (TTM)51.87x
ROI (5Y Avg)-12.62%
LT Debt / Equity (Quarterly)0.00x
EPS Basic Excl Extra (TTM)$-0.10
P/TBV (Quarterly)3.17x
P/B Ratio (Annual)3.13x
Inventory Turnover (TTM)1.15x
Pretax Margin (TTM)-12.56%
Book Value / Share (Annual)$7.72
Price vs S&P 500 (13W)-11.70%
Beta2.05x
P/FCF (Annual)367.87x
Revenue / Share (TTM)$2.00
ROE (TTM)-1.29%
52-Week Low$17.86
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.19
4.19
4.19
4.19
Industry Peers — Electromedical Equipment(29)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
BLFSBioLife Solutions Inc. | 10.84x | 14.87% | 64.56% | -17.26% | $22.19 |
MDTMedtronic plc | 3.13x | 3.01% | 65.16% | 17.00% | $85.00 |
MASIMasimo Corporation | 6.11x | 5.95% | 61.90% | 20.30% | $178.45 |
TMDXTransMedics Group, Inc. Common Stock | 6.41x | 88.21% | 59.92% | 17.93% | $113.13 |
LIVNLivaNova PLC Ordinary Shares | 2.59x | 8.24% | 68.04% | 14.09% | $65.81 |
ITGRInteger Holdings Corporation | 1.66x | 11.55% | 27.39% | 11.90% | $89.32 |
AXGNAxogen, Inc. Common Stock | 8.90x | 14.93% | 74.31% | -3.49% | $37.23 |
CNMDCONMED Corporation | 0.89x | 9.77% | 54.59% | 7.46% | $39.68 |
INMDInMode Ltd. Ordinary Shares | 2.51x | 12.45% | 78.54% | 23.05% | $14.57 |
CBLLCeriBell, Inc. Common Stock | 8.96x | — | 87.89% | -65.57% | $21.13 |
CVCapsoVision, Inc. Common Stock | 22.10x | — | 52.92% | -188.25% | $6.01 |
About
BioLife Solutions provides bioproduction solutions for the cell and gene therapy industry, including cell processing, cold chain, and thawing technologies designed to optimize manufacturing efficiency. The company's primary revenue driver is CryoStor, a biopreservation product for cell processing applications. The vast majority of revenue is generated in the United States market.